Acquired resistance to gemcitabine has been associated with deficiency of dCK [37-40] It has been shown that the expression of dCK at mRNA, protein and activity level in cancer cell lines of different origin were closely related and a correlation between the sensitivity to gemcitabine and the activity of dCK was observed [41]. The gene discussed is DCK; the disease is cancer.